NZ510063A - Abundant extracellular products and methods for their production and use - Google Patents

Abundant extracellular products and methods for their production and use

Info

Publication number
NZ510063A
NZ510063A NZ510063A NZ51006301A NZ510063A NZ 510063 A NZ510063 A NZ 510063A NZ 510063 A NZ510063 A NZ 510063A NZ 51006301 A NZ51006301 A NZ 51006301A NZ 510063 A NZ510063 A NZ 510063A
Authority
NZ
New Zealand
Prior art keywords
protein
production
methods
abundant extracellular
extracellular products
Prior art date
Application number
NZ510063A
Inventor
Marcus A Horwitz
Gunter Harth
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/447,398 external-priority patent/US6761894B1/en
Application filed by Univ California filed Critical Univ California
Publication of NZ510063A publication Critical patent/NZ510063A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A vaccinating agent for use in promoting an effective immune response, in a mammalian host, against an infectious pathogen from the genus Mycobacterium. This vaccinating agent comprises at least a portion of at least one widely abundant extracellular product such as M. tuberculosis 110 KD protein, 80 KD protein, 58 KD protein, 45 KD protein, 24 KD protein, 23.5 KD protein, 14 KD protein, 12 KD protein and respective functional analogs, homologs, and subunits thereof having at least 70% sequence homology of these proteins.
NZ510063A 1995-05-23 2001-02-20 Abundant extracellular products and methods for their production and use NZ510063A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/447,398 US6761894B1 (en) 1993-11-23 1995-05-23 Abundant extracellular products and methods for their production and use
US54592695A 1995-10-20 1995-10-20
US55114995A 1995-10-31 1995-10-31
US56835795A 1995-12-06 1995-12-06
NZ30994501 2001-02-20

Publications (1)

Publication Number Publication Date
NZ510063A true NZ510063A (en) 2002-11-26

Family

ID=27532648

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510063A NZ510063A (en) 1995-05-23 2001-02-20 Abundant extracellular products and methods for their production and use

Country Status (1)

Country Link
NZ (1) NZ510063A (en)

Similar Documents

Publication Publication Date Title
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
ITFI920058A1 (en) CONJUGATE COMPOUNDS FORMED FROM HEAT SHOCK PROTEIN (HSP) AND OLIGO-POLYSACCHARIDES, THEIR USE FOR THE PRODUCTION OF VACCINES.
DE69229476D1 (en) OSPA PROTEINE FROM BORRELIA BURGDORFERI SUB-GROUPS, CODING GENES AND VACCINE SUBSTANCES
GB9808327D0 (en) Antidiotypic compounds
PT807178E (en) MYCOBACTERIAL PROTEINS, MICRO-ORGANISMS THAT PRODUCE THEM AND ITS VACCINE UTILIZATIONS AND TUBERCULOSIS DETECTION
MX9707021A (en) Il-17 receptor.
IT9067217A0 (en) PACKAGING FOR HYGIENIC-HEALTH PRODUCTS, SUCH AS DISPOSABLE NAPERS, PANTS AND SIMILAR.
PL325373A1 (en) Compounds and methods useful in tuberculosos immunotherapy and diagnostics
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
DE3854213T3 (en) Analogs of the subunit of Bordetella toxin derived from recombinant DNA.
MY119003A (en) Bacterial antigens and vaccine compositions
ES2179261T3 (en) STREPTOCOCCUS EQUI BASED VACCINE.
BR9408135A (en) Abundant extra-cellular products and processes for their production and use
PL303482A1 (en) Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine
DE69122240D1 (en) ANTIG-EFFECTING PROTEINS BY BORRELIA BURGDORFERI
DE69634263D1 (en) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
EP0754229A1 (en) Alfamin: a human serum albumin-like protein
FR2748748B1 (en) IDENTIFICATION AND CLONING OF A MYCOBACTERIAL ANTIGEN CORRESPONDING TO A HEPARIN BINDING HEMAGGLUTIN
FR2677365B1 (en) MYCOBACTERIUM PROTEINS AND APPLICATIONS.
PL316935A1 (en) Heparin bonding protein for treating septicaemia and method of obtaining such protein
NZ510063A (en) Abundant extracellular products and methods for their production and use
DE69521200D1 (en) FORMULATION OF ENERGY
CA1263307C (en) Polydisperse native pseudomonas flagellar (h) antigens and a method of producing them
ZA932748B (en) Water-soluble retinoids
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired